RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-3.83%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$928M
AUM Growth
+$928M
(-2.2%)
Cap. Flow
+$42.1M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
34.27%
Holding
87
New
4
Increased
25
Reduced
17
Closed
2
Top Buys
| 1 |
Eli Lilly
LLY
|
$10.2M |
| 2 |
Charles River Laboratories
CRL
|
$8.62M |
| 3 |
Procept Biorobotics
PRCT
|
$7.02M |
| 4 |
Intuitive Surgical
ISRG
|
$6.87M |
| 5 |
Medtronic
MDT
|
$6.5M |
Top Sells
| 1 |
Cigna
CI
|
$10M |
| 2 |
Zimmer Biomet
ZBH
|
$8.75M |
| 3 |
Elevance Health
ELV
|
$7.84M |
| 4 |
UnitedHealth
UNH
|
$7.06M |
| 5 |
Molina Healthcare
MOH
|
$6.54M |
Sector Composition
| 1 | Healthcare | 99.51% |
| 2 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $53.7M | 5.79% | 100,000 +19,000 | +23% | +$10.2M |
|
2
Boston Scientific
BSX
$156B
| $37M | 3.98% | 700,000 +120,000 | +21% | +$6.34M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $33.6M | 3.63% | 380,000 | – | – |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $32.9M | 3.55% | 40,000 +5,000 | +14% | +$4.11M |
|
5
McKesson
MCK
$85.4B
| $30.9M | 3.33% | 71,000 | – | – |
|
|
6
Medtronic
MDT
$119B
| $29.4M | 3.17% | 375,000 +83,000 | +28% | +$6.5M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $26.6M | 2.87% | 76,500 +13,000 | +20% | +$4.52M |
|
8
Abbott
ABT
$231B
| $25.3M | 2.73% | 261,675 +12,675 | +5% | +$1.23M |
|
9
Becton Dickinson
BDX
$55.3B
| $24.6M | 2.65% | 95,000 | – | – |
|
10
Humana
HUM
$36.5B
| $23.8M | 2.57% | 49,000 +3,000 | +7% | +$1.46M |
|
|
11
UnitedHealth
UNH
$281B
| $23.2M | 2.5% | 46,000 -14,000 | -23% | -$7.06M |
|
|
12
Cigna
CI
$80.3B
| $22.9M | 2.47% | 80,000 -34,985 | -30% | -$10M |
|
13
AbbVie
ABBV
$372B
| $22.4M | 2.41% | 150,000 | – | – |
|
14
Tenet Healthcare
THC
$16.3B
| $22.1M | 2.38% | 335,000 +45,000 | +16% | +$2.97M |
|
15
Cencora
COR
$56.5B
| $21.4M | 2.31% | 119,000 | – | – |
|
16
CVS Health
CVS
$92.8B
| $20.9M | 2.26% | 300,000 +52,000 | +21% | +$3.63M |
|
17
HCA Healthcare
HCA
$94.5B
| $20.4M | 2.2% | 83,000 +18,500 | +29% | +$4.55M |
|
|
18
Intuitive Surgical
ISRG
$170B
| $19.7M | 2.13% | 67,500 +23,500 | +53% | +$6.87M |
|
19
Merck
MRK
$210B
| $19.6M | 2.11% | 190,000 | – | – |
|
20
Cooper Companies
COO
$13.4B
| $19.1M | 2.06% | 60,000 +7,200 | +14% | +$2.29M |
|
21
Jazz Pharmaceuticals
JAZZ
$7.75B
| $18.6M | 2% | 143,634 -1,366 | -0.9% | -$177K |
|
22
Gilead Sciences
GILD
$140B
| $17.5M | 1.89% | 234,000 | – | – |
|
|
23
Elevance Health
ELV
$71.8B
| $16.5M | 1.78% | 38,000 -18,000 | -32% | -$7.84M |
|
|
24
Procept Biorobotics
PRCT
$2.23B
| $16.2M | 1.74% | 493,000 +214,000 | +77% | +$7.02M |
|
|
SWAV
25
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $16.1M | 1.74% | 81,000 +25,000 | +45% | +$4.98M |
|